Inovexus Early Stage Fund Master Entity, LP - B3 is a venture capital fund based in Seattle, Washington. According to its most recent Form D, filed Mar 20, 2024, it has sold $89,753 of interests to 17 investors since its first sale in Jul 2023. The minimum investment it accepts from an outside investor is $645. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include LLC Fund GP; Ltd. Belltower Fund Group.
- Total raised
- $89,753Cumulative sales reported on Form D
- Investors
- 17
- First sale
- Jul 12, 2023
- Minimum investment
- $645
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- LLC Fund GP; Ltd. Belltower Fund Group
- Latest Form D
- Mar 20, 2024
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Mar 20, 2024 | Form D/A (amendment) | $89,753 | 17 | SEC.gov ↗ |
| Jul 20, 2023 | Form D | $77,253 | 17 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jul 20, 2023. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Related vehicles with the same name (7)
| Vehicle | Total raised | Investors | Latest Form D |
|---|---|---|---|
| Inovexus Early Stage Fund Master Entity, LP - B2 | $195,202 | 17 | Jun 13, 2023 |
| Inovexus Early Stage Fund Master Entity, LP - B1 | $142,500 | 11 | Jan 11, 2023 |
| Inovexus Early Stage Fund Master Entity, LP - A3 | $137,495 | 12 | Jul 13, 2022 |
| Inovexus Early Stage Fund Master Entity, LP - A4 | $131,220 | 12 | Oct 7, 2022 |
| Inovexus Early Stage Fund Master Entity, LP - B3 (this page) | $89,753 | 17 | Mar 20, 2024 |
| Inovexus Early Stage Fund Master Entity, LP - A1 | $25,000 | 4 | Jan 26, 2022 |
| Inovexus Early Stage Fund Master Entity, LP - A2 | $25,000 | 1 | Apr 18, 2022 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 7 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.
Questions about Inovexus Early Stage Fund Master Entity, LP - B3
What is the minimum investment for Inovexus Early Stage Fund Master Entity, LP - B3?
According to its latest Form D, filed Mar 20, 2024, the minimum investment Inovexus Early Stage Fund Master Entity, LP - B3 accepts from an outside investor is $645.
Who can invest in Inovexus Early Stage Fund Master Entity, LP - B3?
Inovexus Early Stage Fund Master Entity, LP - B3 is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has Inovexus Early Stage Fund Master Entity, LP - B3 raised?
Inovexus Early Stage Fund Master Entity, LP - B3 reports $89,753 sold from 17 investors on its Form D filed Mar 20, 2024. This is cumulative sales since the offering began, not current assets or performance.
Where is Inovexus Early Stage Fund Master Entity, LP - B3 based?
Inovexus Early Stage Fund Master Entity, LP - B3 is based in Seattle, Washington.
When did Inovexus Early Stage Fund Master Entity, LP - B3 launch?
Inovexus Early Stage Fund Master Entity, LP - B3 reports its first sale in Jul 2023.
Size compared with every venture capital fund
Raised more than 21% of the 5,426 venture capital funds based in Washington, and more than 13% of all 14,864 that report sales.